Supplemental material
Report
GingisKHAN™ protease cleavage allows a high-throughput antibody to Fab conversion enabling direct functional assessment during lead identification of human monoclonal and bispecific IgG1 antibodies
, 
, , , , , , & show all
Manuel EndesfelderRoche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Nonnenwald 2, Penzberg, Germanyhttp://orcid.org/0000-0001-8267-249X
http://orcid.org/0000-0001-8267-249X, , , , , , Ulrike ReiffRoche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Nonnenwald 2, Penzberg, Germanyhttp://orcid.org/0000-0001-8969-6937
http://orcid.org/0000-0001-8969-6937 & show all